Published in Cochrane Database Syst Rev on July 08, 2009
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med (2010) 6.51
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cochrane Database Syst Rev (2012) 1.11
Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure. J Allergy Clin Immunol (2010) 0.95
The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2016) 0.85
Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma. Curr Opin Pediatr (2010) 0.81
Inhaled corticosteroids in childhood asthma: the story continues. Eur J Pediatr (2010) 0.81
Loss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonists. Pulm Med (2012) 0.80
The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J (2016) 0.77
Childhood asthma: diagnosis and treatment. Scientifica (Cairo) (2012) 0.77
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy. Respir Res (2016) 0.76
A systematic review with attempted network meta-analysis of asthma therapy recommended for five to eighteen year olds in GINA steps three and four. BMC Pulm Med (2012) 0.75
Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma. Paediatr Child Health (2014) 0.75
Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review. Lung (2013) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol (2007) 15.45
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med (2004) 4.37
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol (2006) 2.79
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev (2006) 2.30
Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol (2003) 1.92
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84
Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med (1998) 1.72
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J (2005) 1.70
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest (2005) 1.66
Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med (2008) 1.64
Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63
Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics (1997) 1.62
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin (2004) 1.57
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev (2005) 1.56
Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med (2005) 1.52
A randomized controlled trial of an asthma clinical pathway for children in general practice. Acta Paediatr (2005) 1.49
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves. Ann Allergy Asthma Immunol (2005) 1.45
Efficacy and tolerability of formoterol Turbuhaler in children. Int J Clin Pract (2003) 1.43
Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Ann Allergy Asthma Immunol (2004) 1.41
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected]. Clin Exp Allergy (2005) 1.37
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest (2006) 1.33
Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol (2002) 1.21
Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.20
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev (2005) 1.19
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev (2007) 1.17
Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev (2005) 1.12
Beclomethasone for asthma in children: effects on linear growth. Cochrane Database Syst Rev (2000) 1.10
Salmeterol xinafoate in children on high dose inhaled steroids. Ann Allergy Asthma Immunol (1995) 1.08
Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med (1999) 1.08
Traditional and patient-centred outcomes with three classes of asthma medication. Eur Respir J (2005) 1.04
Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.01
Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma. Respir Med (1995) 1.00
Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respir Med (2005) 0.94
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.93
Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol (2007) 0.91
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.91
Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol (2004) 0.91
Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med (1995) 0.90
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med (2004) 0.89
Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma. J Asthma (2004) 0.89
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol (2005) 0.88
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. Respir Med (2007) 0.86
A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther (2006) 0.85
Ciclesonide versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 0.85
Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pediatr Allergy Immunol (2006) 0.84
Acute asthma intervention: insights from the STAY study. J Allergy Clin Immunol (2007) 0.84
A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide. Arch Dis Child (2000) 0.83
Improving asthma treatment in a managed care population. Am J Manag Care (2005) 0.83
Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. Pediatr Allergy Immunol (2004) 0.83
Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. Pulm Pharmacol Ther (2007) 0.82
Eformoterol Turbohaler compared with salmeterol by dry powder inhaler in asthmatic children not controlled on inhaled corticosteroids. Pediatr Allergy Immunol (2004) 0.82
Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare. Allergy Asthma Proc (2005) 0.82
The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma. Ann Allergy Asthma Immunol (2005) 0.82
Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol (2004) 0.82
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. Curr Med Res Opin (2004) 0.81
Maintenance and symptom relief with budesonide plus formoterol reduced severe asthma exacerbations. Evid Based Nurs (2005) 0.81
Formoterol used as needed in patients with intermittent or mild persistent asthma. Respir Med (2005) 0.80
Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma. Swiss Med Wkly (2004) 0.79
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. Pharmacoeconomics (2005) 0.79
Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med (2004) 0.78
The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children. Allergy Asthma Proc (2007) 0.78
Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma. Respir Med (2005) 0.78
Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma. Ann Allergy Asthma Immunol (2005) 0.78
Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma. Clin Drug Investig (2005) 0.78
Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial. Arch Dis Child (1999) 0.78
Fixed and adjustable dose asthma action plans based on combination therapy: a pilot study. Respirology (2005) 0.77
Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens. Allergy Asthma Proc (2005) 0.77
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthma. Respirology (2006) 0.77
Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids. Int J Clin Pract (2005) 0.77
[The quality of life of the asthmatic child caregiver]. Gac Med Mex (2004) 0.77
Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma. Fundam Clin Pharmacol (2003) 0.77
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Ann Allergy Asthma Immunol (2005) 0.77
A population-based evaluation of a regional asthma education centre. Can Respir J (2004) 0.76
Mucociliary clearance in patients with chronic asthma: effects of beta agonists. Respirology (2005) 0.76
An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med (2007) 4.10
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev (2010) 2.91
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev (2013) 2.17
Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ (2005) 2.12
Systematic review of randomized controlled trials examining written action plans in children: what is the plan? Arch Pediatr Adolesc Med (2008) 2.06
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2012) 1.95
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev (2011) 1.80
Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol (2007) 1.80
Influenza vaccination for healthcare workers who work with the elderly: systematic review. Vaccine (2010) 1.71
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev (2014) 1.63
Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2009) 1.58
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2010) 1.58
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 1.57
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev (2014) 1.44
Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev (2013) 1.42
Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev (2009) 1.38
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev (2013) 1.34
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2014) 1.24
Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.20
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2009) 1.16
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev (2009) 1.14
Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. Evid Based Child Health (2014) 1.13
Prospective validation of the pediatric appendicitis score in a Canadian pediatric emergency department. Acad Emerg Med (2009) 1.09
Inhaled corticosteroids in children with persistent asthma: effects on growth. Evid Based Child Health (2014) 1.08
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev (2012) 1.03
Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. Cochrane Database Syst Rev (2014) 1.02
Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (2008) 1.01
A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr (2002) 1.00
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev (2011) 1.00
Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Ann Emerg Med (2012) 0.99
Impulse oscillometry: reference values in children 100 to 150 cm in height and 3 to 10 years of age. Chest (2005) 0.97
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.93
Effect of maternal moderate to severe asthma on perinatal outcomes. Respir Med (2010) 0.93
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.92
Diagnosis and management of asthma in preschoolers: A Canadian Thoracic Society and Canadian Paediatric Society position paper. Can Respir J (2015) 0.91
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.91
Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J (2012) 0.89
Best strategies to implement clinical pathways in an emergency department setting: study protocol for a cluster randomized controlled trial. Implement Sci (2013) 0.88
Implanting telehealth network for paediatric cardiology: learning from the Quebec experience. Cardiol Young (2004) 0.88
Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J (2010) 0.88
Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children. Cochrane Database Syst Rev (2015) 0.87
Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev (2016) 0.87
Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. Cochrane Database Syst Rev (2013) 0.86
Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.85
Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women. Respir Med (2008) 0.82
Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J (2013) 0.81
Adenotonsillectomy improves sleep, breathing, and quality of life but not behavior. J Pediatr (2007) 0.81
Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children. Respir Med (2010) 0.80
Acute asthma in children and adolescents: should inhaled anticholinergics be added to beta(2)-agonists? Am J Respir Med (2003) 0.79
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.79
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 0.79
Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev (2015) 0.79
Leukotriene receptor antagonists as first line or add-on treatment for asthma. BMJ (2011) 0.78
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev (2012) 0.78
Management of acute bronchiolitis. BMJ (2011) 0.78
Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy. Pharmacotherapy (2012) 0.77
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 0.77
Development and pretesting of an electronic learning module to train health care professionals on the use of the Pediatric Respiratory Assessment Measure to assess acute asthma severity. Can Respir J (2013) 0.76
WITHDRAWN. Inhaled steroids for neonatal chronic lung disease. Cochrane Database Syst Rev (2010) 0.76
Oral corticosteroids in children with wheezing. N Engl J Med (2009) 0.76
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.75
High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs. Eur Respir J (2012) 0.75
Cochrane in context: Inhaled corticosteroids in children with persistent asthma: effects on growth and dose-response effects on growth. Evid Based Child Health (2014) 0.75
Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Paediatr Respir Rev (2013) 0.75
Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database Syst Rev (2014) 0.75
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2016) 0.75
Continuous versus intermittent inhaled corticosteroids for mild persistent asthma in children: not too much, not too little. Thorax (2011) 0.75
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Sao Paulo Med J (2010) 0.75